Trestle reports higher revenues but greater net loss in 2Q

Trestle Holdings Inc. experienced revenue growth in the second quarter of 2004, reporting revenues of $1.375 million, compared with $112,000 in the second quarter of 2003. Yet, the company reported a net loss of $1.203 million, compared with $928,000 in the year-ago quarter.

According to Trestle, the growth in sales resulted from new and follow-on sales of the company's MedMicro digital imaging product family, partially offset by decreases in sales for the company's telemedicine product MedReach. Trestle also noted that amounts for the year earlier period are not directly comparable because they pre-date the acquisition of Trestle Corp. and the effect of discontinued operations, which represented substantially all the company's operations during such periods.

Around the web

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.